Effect of recombinant human erythropoietin on postoperative anemia in children and adolescents undergoing osteosarcoma and potential influencing factors: a single-center retrospective study
For hospitalized children and adolescents suffering from postoperative anemia following osteosarcoma surgery, rhEPO treatment can significantly shorten their hospital stay. Preoperative administration of rhEPO may be a key factor in rapidly helping patients to survive the postoperative hemoglobin trough. Given the inherent limitations of retrospective studies, further prospective research is warranted to validate these findings.
Authors
- Difei Yao
- Wenjun Yang (ORCID: https://orcid.org/0000-0002-4604-9542)
- Lingyan Yu (ORCID: https://orcid.org/0000-0001-7828-139X)
- Meili Lin (ORCID: https://orcid.org/0009-0008-8906-4970)
- Haibin Dai (ORCID: https://orcid.org/0000-0002-5768-2714)
- Lulu Liu (ORCID: https://orcid.org/0000-0002-2563-3379)
- Huan Luo (ORCID: https://orcid.org/0000-0001-7886-8967)
Institutions
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-05
- DOI
- https://doi.org/10.3389/fphar.2025.1637441
- Citations
- 1
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Zhejiang Pharmaceutical Association